EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Dietary supplementation with omega-3 fatty acids in patients with active rheumatoid arthritis: a double blind placebo controlled study



Dietary supplementation with omega-3 fatty acids in patients with active rheumatoid arthritis: a double blind placebo controlled study



Revista Medica de Chile 119(3): 267-272



The effect of dietary supplementation with eicosapentaenoic acid was evaluated in 8 patients with active rheumatoid arthritis. Patients were given fish oil supplements containing eicosapentaenoic acid 4 g, docosahexaenoic acid 2 g and gamma -tocopherol 15 IU, daily. An appropriate placebo was given to 8 control subjects. After 12 weeks of therapy a significant improvement in grip-strength was detected in patients receiving active treatment, while other clinical parameters remained unchanged.

(PDF 0-2 workdays service: $29.90)

Accession: 002072134

Download citation: RISBibTeXText



Related references

Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. A 12-month, double-blind, controlled study. Arthritis and Rheumatism 37(6): 824-829, 1994

Effects of altering dietary essential fatty acids on requirements for non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis: a double blind placebo controlled study. Annals of the Rheumatic Diseases 47(2): 96-104, 1988

Active rheumatoid arthritis: effect of dietary supplementation with omega-3 oils. A controlled double-blind trial. Revista Medica de Chile 119(3): 267-272, 1991

The Effect of Omega-3 Fatty Acids in Patients With Active Rheumatoid Arthritis Receiving DMARDs Therapy: Double-Blind Randomized Controlled Trial. Global Journal of Health Science 8(7): 18-25, 2016

Omega-3 fatty acids as adjuvant therapy in rheumatoid arthritis. A double-blind, randomized, placebo-controlled trial. 2006

Regarding "omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study". Biological Psychiatry 63(2): E13; Author Reply E15-E13; Author Reply E15, 2007

Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study. Biological Psychiatry 61(4): 551-553, 2006

Effect of n-3 polyunsaturated fatty acid supplementation in patients with rheumatoid arthritis: a 16-week randomized, double-blind, placebo-controlled, parallel-design multicenter study in Korea. Journal of Nutritional Biochemistry 24(7): 1367-1372, 2014

Omega-3 fatty acids supplementation in Mexican patients with rheumatoid arthritis with standard treatment A blinded, randomized, placebo controlled, one year, clinical trial. Arthritis & Rheumatism 41(9 SUPPL ): S155, Sept, 1998

The effects of dietary supplementation with n-3 polyunsaturated fatty acids in patients with rheumatoid arthritis: A randomized, double blind trial. European Journal of Clinical Investigation 22(10): 687-691, 1992

The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. Annals of Internal Medicine 130(7): 554-562, 1999

A randomized double-blind controlled study of 6 months of oral nutritional supplementation with arginine and OMEGA-3 fatty acids in HIV-infected patients. AIDS (London) 12(1): 53-63, Jan 1, 1998

Studies of dietary supplementation with omega 3 fatty acids in patients with rheumatoid arthritis. World Review of Nutrition and Dietetics 66: 367-382, 1991